Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Patent
1994-08-12
1997-12-09
Hutzell, Paula K.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
435 691, 4353201, 536 235, C12N 516, C07H 2104
Patent
active
056959931
ABSTRACT:
Human protein C and activated protein C were shown to bind to endothelium specifically, selectively and saturably (Kd=30 nM, 7000 sites per cell) in a Ca.sup.2+ dependent fashion. Expression cloning revealed a 1.3 kb CDNA that coded for a novel type I transmembrane glycoprotein capable of binding protein C. This protein appears to be a member of the CD1/MHC superfamily. Like thrombomodulin, the receptor involved in protein C activation, the endothelial cell protein C receptor (EPCR) function and message are both down regulated by exposure of endothelium to TNF. Identification of EPCR as a member of the CD1/MHC superfamily provides insights into the role of protein C in regulating the inflammatory response, and determination of methods for pharmaceutical use in manipulating the inflammatory response.
REFERENCES:
patent: 3625214 (1971-12-01), Higuchi
patent: 4244946 (1981-01-01), Rivier et al.
patent: 4305872 (1981-12-01), Johnston et al.
patent: 4316891 (1982-02-01), Guillemin et al.
patent: 4629784 (1986-12-01), Stammer
patent: 4789734 (1988-12-01), Pierschbacher
patent: 4792525 (1988-12-01), Ruoslahti et al.
patent: 4868116 (1989-09-01), Morgan et al.
patent: 4906474 (1990-03-01), Langer et al.
patent: 4925673 (1990-05-01), Setiner et al.
patent: 4980286 (1990-12-01), Morgan et al.
patent: 5009889 (1991-04-01), Taylor et al.
Rothbarth et al., J. Cell Science, vol. 104, pp. 19-30, Jan., 1993.
Agrawal, S., et al., "Oligodeoxynucleoside Phosphoramidates and Phosphorothioates as Inhibitors of Human Immunodeficiency Virus", Proc. Natl. Acad. Sci. USA, 85:7079-7083 (Oct., 1988).
Askew, B., et al., "Molecular Recognition with Convergent Functional Groups. 6. Synthetic and Structural Studies with a Model Receptor for Nucleic Acid Components", J. Am. Chem. Soc., 111:1082-1090 (1989).
Blume, S.W., et al., "Triple helix Formation by Purine-rich Oligonucleotides Targeted to the Human Dihydrofolate Reductase Promoter", Nucl. Acids Res., 20:1777-1784 (1992).
Bock, P.E., "Active Site Selective Labeling of Serine Proteases with Spectroscopic Probes Using Thioester Peptide Chloromethyl Ketones: Demonstration of Thrombin Labeling Using N.sup..alpha. 27:6633-6639 (1988).
Clackson, T., et al., "Making Antibody Fragments Using Phage Display Libraries", Nature, 352:624-688 (Aug., 1991).
Conway, E.M., et al., "Tumor Necrosis Factor Suppresses Transcription of the Thrombomodulin Gone in Endothelial Cells", Mol. Cell. Biol, 8:5588-5592 (Dec., 1988).
Cooney, M., et al., "Site-Specific Oligonucleotide Binding Represses Transcription of the Human c-myc Gene In Vitro". Science, 241:458-459 (Jul., 1988).
Crooke, S.T., "Progress Toward Oligonucleotide Therapeutics: Pharmacedynamic Properties", FASEB J., 7:533-539 (Apr., 1993).
Dahlback, B., "Protein S and C4b-Binding Protein: Components Involved in the Regulation of the Protein C Anticoagulant System", Thromb. Haemostas., 66:49-61 (1991).
Dahlback, B., "Inhibition of Protein C.sub.a Cofactor Function of Human and Bovine Protein S by C4b-binding Protein", J. Biol. Chem., 261:12022-12027 (Sep., 1986).
Dahlback, B., "Binding of Anticoagulant Vitamin K-Dependent Protein S to Platelet-Derived Microparticles", Biochemistry, 31:12769-12777 (1992).
Daugherty, B.L., et al., "Polymerase Chain Reaction Facilitates the Cloning, CDR-Grafting, and rapid Expression of a Murine Monoclonal Antibody directed Against the CD18 Component of Leukocyte Integrins", Nucl. Acids Res., 19:2471-2476 (1991).
Dittman, W.A., "Thrombomodulin--Biology and Potential Cardiovascular Applications", Trends Cardiovasc. Med., 1:331-336 (1991).
Dittman, W.A., et al., "Structure and Function of Thrombomodulin: A Natural Anticoagulant", Blood, 75:329-336 (Jan., 1990).
Dreyfus, M., et al., "Treatment of Homozygous Protein C Deficiency and Neonatal Purpura Fulminans With a Purified Protein C Concentrate", N. Engl. J. Med., 325:1565-1568 (1991).
Duval-Valentin, G., et al., "Specific Inhibition of Transcription by Triple helix-forming Oligonucleotides", Proc. Natl. Acad. Sci. USA, 89:504-508 (Jan., 1992).
Engelman, D.M., et al., "Identifying Nonpolar Transbilayer Helices in Amino Acid Sequences of Membrane Proteins", Annu. Rev. Biophys. Biophys. Chem., 15:321-53 (1986).
Esmon, C.T., "The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation", J. Biol. Chem., 264:4743-4746 (Mar., 1989).
Esmon, C.T., et al., "Protein C Activation", Meths. Enzymol., 222:359-385 (1993).
Esmon, C.T., "Protein S and Protein C--Biochemistry, Physiology, and Clinical Manifestation of Deficiencies", Trends Cardiovasc. Med., 2:214-220 (1992).
Gerson, W.T., et al., "Severe Acquired Protein C Deficiency in Purpura Fulminans Associated With Disseminated Intravascular Coagulation: Treatment With Protein C Concentrate", Pediatrics, 91:418-422 (Feb., 1993).
Graham, F.L., et al., "A New Technique for the Assay of Infectivity of Human Adenovirus 5 DNA", Virology, 52:456-467 (1973).
Gregoriadis, G., "Liposomes", Drug Carriers in Biology and Medicine, 287-341 (Academic Press, 1979).
Grey, S., et al., "Selective Effects of Protein C on Activation of Human Monocytes by Lipopolysaccharide, Interferon-Y, or PMA: Modulation of Effects on CD11b and CD14 but not CD25 or CD54 Induction", Transplant. Proc., 25:2913-2914 (Oct., 1993).
Grigoriev, M., et al., "A Triple Helix-forming Oligonucleotide-Intercalator Conjugate Acts as a Transcriptional Repressor via Inhibition of NF .kappa.B Binding to Interleukin-2 Receptor .alpha.-Regulatory Sequence", J. Biol. Chem., 267:3389-3395 (Feb., 1992).
Grinnell, B.W., et al., "Human Protein C Inhibits Selectin-mediated Cell Adhesion: Role of Unique Fucosylated Oligosaccharide", Glycobiology, 4:221-226 (1994).
Hogg, P.J., et al., "Identification of Structural Domains in Protein C Involved in its Interaction with Thrombin-Thrombomodulin on the Surface of Endothelial Cells", J. Biol. Chem., 267:703-706 (Jan., 1992).
Holt, J.T., et al., "An Oligomer Complementary to c-myc mRNA Inhibits Proliferation of HL-60 Promyelocytic Cells and Induces Differentiation", Mol. Cell Biol., 8:963-973 (Feb., 1988).
Ikuta, K., et al., "Synthesis and Use of Synthetic Oligonucleotides", Ann. Rev. Biochem., 53:323-356 (1984).
Kaisho, T., et al., "BST-1, A Surface Molecule of Bone Marrow Stromal Cell Lines That Facilitates Pre-B-Cell Growth", Proc. Natl. Acad. Sci. (USA), 91:5325 (Jun., 1994).
Kapiotis, S., et al., "Interleukin-4 Counteracts Pyrogen-lnduced Downrequlation of Thrombomodulin in Cultured Human Vascular Endothelial Cells", Blood, 78:410-415 (Jul., 1991).
Kozak, M., "Point Mutations Define a Sequence Flanking the AUG Initiator Codon That Modulates Translation by Eukaryotic Ribosomes", Cell, 44:283-292 (Jan., 1986).
Kyte, J., et al., "A Simple Method for Displaying the Hydropathic Character of a Protein", J. Mol. Biol., 157:105-132 (1982).
Le Bonniec, B.F., et al., "The Role of Calcium Ions in Factor X Activation by Thrombin E192Q", J. Biol. Chem., 267:6970-6976 (Apr., 1992).
Ledbetter, J.A., et al., "Covalent Association Between Human Thymus Leukemia-like Antigens and CDB(Tp32) Molecules", J. Immunol., 134:4250-4254 (Jun., 1985).
Lentz, S.R., et al., "Regulation of Thrombomodulin by Tumor Necrosis Factor-.alpha.: Comparison of Transcriptional and Posttranscriptional Mechanisms", Blood, 77:543-550 (Feb., 1991).
Lewis, R.A., et el., "Automated Site-directed Drug Design: The Concept of Spacer Skeletons for Primary Structure Generation", Proc. R. Soc. Lond., 236:125-140 and 141-182 (1989).
Maciag, T., et al., "An Endothelial Cell Growth Factor From Bovine Hypothalamus: Identification and Partial Characterization", Proc. Natl. Acad. Sci. (USA), 76:5674-5678 (Nov., 1979).
Maher, L.J., et al., "Inhibition of DNA Binding Proteins by Oligonucleotide-Directed Triple Helix Formation", Science, 245:725-730 (Aug., 1989).
Maruyama, I., et al., "Increased Expression of Thrombomodulin on the Cultured Human Umbilical Vein Endothelial Cells and Mouse Hemangioma Cells by Cyclic AMP", Thrombosis Research, 61:301-310 (1991).
McKinaly, J.A., et al., "Rational Design of Antiviral Agents", Annu. Rev. Pharmacol. Toxicol., 29:1
Esmon Charles T.
Fukudome Kenji
Gucker Stephen
Hutzell Paula K.
Oklahoma Medical Research Foundation
LandOfFree
Cloning and regulation of an endothelial cell protein C/activate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cloning and regulation of an endothelial cell protein C/activate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cloning and regulation of an endothelial cell protein C/activate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1607031